Scott Douglas

Photo of Scott Douglas

Scott Douglas is a senior policy director in Crowell & Moring's Government Affairs and Health Care groups. His practice focuses on assisting clients with legislative and regulatory issues. Scott uses his significant health care public policy experience to assist health care companies, managed care, long-term care, long-term care pharmacy facilities, trade associations, and others with legislation before the U.S. Congress.

Scott has experience working in highly diverse settings, including Fortune 500 companies and a contract lobbying firm. He ran multi-state lobbying operations, working directly with decision makers and overseeing external lobbyists. Scott directed the state government affairs program for the 47-state operation of a Fortune 400 health care company, monitored developing legislation, and developed and executed lobbying strategies. He was also a principal lobbyist at Capital Link Consultants, a leading Kentucky lobbying firm, and successfully represented clients from the health care, consumer finance, education, manufacturing, retail, insurance, and information technology sectors.

In addition to his government affairs background, Scott worked as the finance director for United States Senator Mitch McConnell, the current Senate Majority Leader. He also served as the Kentucky campaign manager for Bush-Cheney 2000 and as the political director for United States Senator Jim Bunning's 1998 campaign. Drawing from his experience in political campaigns, Scott also advises clients on effectively using grassroots, public relations, and crisis communications as an important component of broad-based government relations strategies.

Scott earned his B.A. from Eastern Kentucky University.

Latest Articles

Webinar on May 17, 2019 Starts: 12:00 PM (EDT) Ends: 12:30 PM (EDT) Join the Crowell & Moring trade team for a 30-minute update on the U.S.-China trade negotiations, the imposition of tariffs, and the continued escalation of tensions from the White House.  Hear the latest on President Trump’s potential next steps, the status of the product exclusion process for Lists 1, 2, and 3, and how to respond to the recent announcement of List…
The Congressional election on November 6, 2018 produced a new split Congress with a House Democratic majority and a Senate Republican majority starting in January 2019. The difference between the outgoing 115th Congress, with a Republican House and Senate, and the 116th Congress starting in 2019 will be significant for U.S. businesses. While the divided Congress brings opportunities to advance bipartisan legislation involving infrastructure, energy, and pharmaceuticals, the new House Democratic majority in the 116th…